Celltrion seeks $897m IPO in Korea with July launch
Celltrion Healthcare has firmed up the price range for its up to W1tr ($897m) flotation on South Korea’s Kosdaq, with bookbuilding set to kick off in mid-July.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: